Literature DB >> 11275533

Cerebellar stimulation in acute cerebellar ataxia.

K Matsunaga1, T Uozumi, T Hashimoto, S Tsuji.   

Abstract

OBJECTIVES: To report follow-up studies of cerebellar stimulation in patients with acute cerebellar ataxia (ACA).
METHODS: We studied two patients with ACA. One patient also had decreased deep sensations in the feet due to combined diseases such as diabetic polyneuropathy and lumbosacral radiculopathies. We applied the technique of electrical stimulation over the cerebellum which was reported previously (Ugawa et al., J Physiol 441 (1991a) 57).
RESULTS: Conditioning stimulation over the cerebellum did not reduce the size of motor-evoked potentials to test magnetic stimulation of the motor cortex at conditioning-test intervals of 5, 6, and 7 ms in the acute stage in both patients. However, normal suppression was recognized in the recovery stage in both patients.
CONCLUSIONS: This technique was useful for follow-up evaluation of cerebellar function in patients with ACA and was also useful for distinguishing cerebellar ataxia from sensory ataxia in a patient with combined diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11275533     DOI: 10.1016/s1388-2457(01)00476-x

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  3 in total

Review 1.  Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.

Authors:  W Ilg; M Branscheidt; A Butala; P Celnik; L de Paola; F B Horak; L Schöls; H A G Teive; A P Vogel; D S Zee; D Timmann
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

Review 2.  The effects of cerebellar stimulation on the motor cortical excitability in neurological disorders: a review.

Authors:  Nobue K Iwata; Yoshikazu Ugawa
Journal:  Cerebellum       Date:  2005       Impact factor: 3.648

3.  Corticospinal activation confounds cerebellar effects of posterior fossa stimuli.

Authors:  Karen M Fisher; H Ming Lai; Mark R Baker; Stuart N Baker
Journal:  Clin Neurophysiol       Date:  2009-12       Impact factor: 3.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.